The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Isomorphic Labs launches into an already well-populated drug discovery category, with many large drugmakers exploring the technology along with a host of specialist players like Exscientia ...

The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. Isomorphic is ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. The potential of ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOGL) stands against the other AI stocks. AI is ...